Skip to content

Wednesday, August 27, 2025

Latest:

Between the bread: Nutrition considerations for lunch meat and sandwiches
Ask Me About My Research with Dr. Jennifer Leonard
Prevent drowning with these water safety tips
Silent but Deadly: Chagas Disease and the Rise of A Tropical Illness in the RGV
True professionalism lives in the small moments

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

ACTL6A

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs: Image of the Month

From the Labs: a closer look at Barrett's esophagus

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951